Search results
Results from the WOW.Com Content Network
Piramal Pharma Limited is active in business verticals including pharmaceuticals, healthcare and life sciences.Its business divisions include Piramal Pharma Solutions, a contract development and manufacturing organization; Piramal Critical Care, a manufacturer of inhalational anesthetics and other hospital generics; and Piramal Consumer Products Division, an over-the-counter consumer ...
Ajay Gopikisan Piramal (born 3 August 1955) is an Indian billionaire businessman, and the chairman of the Piramal Group, a conglomerate with interests in pharmaceutical, financial services, real estate, healthcare analytics and glass packaging. [1] [2] As of July 2024, his net worth is estimated at US$2.8 billion. [3]
Prior to its acquisition by the Piramal Group in 1984, the company's manufacturing plant was located in Kosamba, Gujarat. In 1990, Gujarat Glass Pvt. Ltd. merged with its parent company Nicholas Piramal India Ltd. to become one of its many divisions. [4] [5] In 2020, The Blackstone Group announced that it would acquire Piramal Glass for US$ 1 ...
Cannabis stock GW Pharma (GWPH) has announced that the US Food and Drug Administration (FDA) has approved Epidiolex oral solution for the treatment of seizures associated with tuberous sclerosis ...
Swati Ajay Piramal (née Shah; born 28 March 1956) is an Indian scientist and businesswoman, she also involved in healthcare, focusing on public health and innovation. She is the vice chairperson of Piramal Group, a business conglomerate with interests in pharmaceuticals, financial services, real estate and glass packaging.
For premium support please call: 800-290-4726 more ways to reach us
Piramal Capital and Housing Finance Limited (earlier Dewan Housing Finance Corporation Ltd. (DHFL)) is a non-deposit taking housing finance company, ...
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [ 1 ] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of active pharmaceutical ingredients locally produced. [ 1 ]